 | Up a level |
2022
Scheffler, Matthias, Wiesweg, Marcel, Michels, Sebastian, Nogova, Lucia, Kron, Anna, Herold, Thomas, Scheel, Andreas H., Metzenmacher, Martin, Eberhardt, Wilfried E., Reis, Henning 
ORCID: 0000-0003-1373-5295, Fassunke, Jana, Darwiche, Kaid ORCID: 0000-0003-0681-1325, Aigner, Clemens, Schaufler, Diana, Riedel, Richard, Fischer, Rieke, Koleczko, Sophia, Schildhaus, Hans-Ulrich, Merkelbach-Bruse, Sabine, Schmid, Kurt W., Buettner, Reinhard, Wolf, Juergen and Schuler, Martin
(2022).
Rebiopsy in advanced non-small cell lung cancer, clinical relevance and prognostic implications.
Lung Cancer, 168.
S. 10 - 21.
CLARE:
ELSEVIER IRELAND LTD.
ISSN 1872-8332
2014
Nogova, Lucia, Gardizi, Masyar, Christiaan, Marc, Bos, Allardt, Scheffler, Matthias, Mattonet, Christian, Heukamp, Lukas Carl, Schildhaus, Hans-Ulrich, Fuhr, Uwe, Eberhardt, Wilfried, Reis, Henning, Wiesweg, Marcel, Schmid, Kurt Werner, Schoch, Gernot, Ko, Yon-Dschun, Serke, Monika Heidi, Schuler, Martin H., Buettner, Reinhard and Wolf, Juergen (2014). TRY: A phase II study to evaluate safety and efficacy of combined trastuzumab and AUY922 in advanced non-small cell lung cancer (NSCLC) with HER2 overexpression or amplification or mutation. J. Clin. Oncol., 32 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755